Todd A. Mahr, MD, FACAAI began his service as the College’s Executive Medical Director (EMD) on Jan. 1. He succeeds Michael S. Blaiss, MD, FACAAI, who ended his six years as EMD on Dec. 31, 2022. Dr. Blaiss succeeded Bob Q. Lanier, MD, FACAAI, the College’s first EMD, who served from 2009- 2016.
Dr. Mahr has a long history of involvement with the College. He has been a College member since 1987, served on the ACAAI Board of Regents and was College president in 2018-2019. He gave the Bela Schick lecture in 2015, received the Distinguished Fellow Award in 2014 and the Distinguished Service Award in 2008.
“It’s a great honor to be selected as the next EMD of the College,” said Dr. Mahr. “I’ll be working with College leadership to help advance the specialty,” said Dr. Mahr.
Dr. Mahr’s experience from his roles in clinical practice and academia makes him well suited to provide guidance and strategy to the College in navigating the challenges in today’s health care environment and their effect on the practicing allergist.
“I’m excited to work to ensure the College is the leader in innovative education, practice management, and advocacy for allergists,” said Dr. Mahr.
